For the quarter ending 2025-09-30, MIRM has $785,115K in assets. $493,069K in debts. $282,021K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 282,021 | 228,122 | ||
| Short-term investments | 93,527 | 76,430 | ||
| Accounts receivable | 107,132 | 106,836 | ||
| Inventory | 24,021 | 22,941 | ||
| Prepaid expenses and other current assets | 23,874 | 19,069 | ||
| Total current assets | 530,575 | 453,398 | ||
| Restricted cash | 480 | 480 | ||
| Long-term investments | 2,470 | 17,112 | ||
| Property and equipment, net | 1,277 | 1,177 | ||
| Operating lease right-of-use assets | 8,500 | 8,946 | ||
| Intangible assets, net | 231,895 | 237,870 | ||
| Other assets | 9,918 | 6,842 | ||
| Total assets | 785,115 | 725,825 | ||
| Accounts payable | 12,167 | 17,657 | ||
| Accrued expenses and other current liabilities | 148,192 | 127,139 | ||
| Total current liabilities | 160,359 | 144,796 | ||
| Operating lease liabilities, noncurrent | 7,361 | 7,884 | ||
| Convertible notes payable, net, noncurrent | 309,368 | 308,933 | ||
| Other liabilities | 15,981 | 9,054 | ||
| Total liabilities | 493,069 | 470,667 | ||
| Common stock, 0.0001 par value 200,000,000 shares authorized 51,314,176 and 48,338,096 shares issued and outstanding as of september30, 2025 and december31, 2024, respectively | 5 | 5 | ||
| Additional paid-in capital | 953,818 | 919,520 | ||
| Accumulated deficit | -661,814 | -664,719 | ||
| Accumulated other comprehensive income (loss) | 37 | 352 | ||
| Total stockholders equity | 292,046 | 255,158 | ||
| Total liabilities and stockholders equity | 785,115 | 725,825 | ||
Mirum Pharmaceuticals, Inc. (MIRM)
Mirum Pharmaceuticals, Inc. (MIRM)